FWCFX | RNPAX | FWCFX / RNPAX | |
Total Expense Ratio | 1.73 | 1.49 | 116% |
Annual Report Gross Expense Ratio | 1.73 | 1.49 | 116% |
Fund Existence | 17 years | 23 years | - |
Gain YTD | 11.707 | 16.921 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.39B | 161B | 2% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -2.79 | 9.60 | -29% |
Returns for 3 years | 53.67 | 57.78 | 93% |
Returns for 5 years | 15.51 | 34.61 | 45% |
Returns for 10 years | 71.19 | 99.83 | 71% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTDZX | 151.86 | 2.65 | +1.78% |
Franklin Biotechnology Discovery Adv | |||
FEXRX | 11.96 | 0.11 | +0.93% |
First Eagle U.S. SMID Cap Opportunity R6 | |||
TRCVX | 29.05 | 0.25 | +0.87% |
Nuveen Large Cap Value Idx Retire | |||
FMCDX | 44.22 | N/A | N/A |
Fidelity Advisor Stock Selec Mid Cp A | |||
NAWGX | 51.41 | N/A | N/A |
Voya Global High Dividend Low Vol A |